These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Roh M; Laíns I; Shin HJ; Park DH; Mach S; Vavvas DG; Kim IK; Miller JW; Husain D; Miller JB Br J Ophthalmol; 2019 Dec; 103(12):1769-1776. PubMed ID: 30709810 [TBL] [Abstract][Full Text] [Related]
27. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density. Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628 [TBL] [Abstract][Full Text] [Related]
28. Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography. Chung YR; Kim YH; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K Sci Rep; 2021 Aug; 11(1):17198. PubMed ID: 34433894 [TBL] [Abstract][Full Text] [Related]
29. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group. Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012 [TBL] [Abstract][Full Text] [Related]
30. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy. Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268 [TBL] [Abstract][Full Text] [Related]
31. ELLIPSOID ZONE RECOVERY IN MACULAR TELANGIECTASIA TYPE 2. Goerdt L; Raming K; Rodriguez Garcia JL; Pfau K; Holz FG; Herrmann P Retina; 2024 Aug; 44(8):1413-1421. PubMed ID: 38513243 [TBL] [Abstract][Full Text] [Related]
32. Relation of interdigitation zone changes and right-angle vessels in Macular Telangiectasia Type-2 (MacTel). Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S Eye (Lond); 2023 Oct; 37(14):2977-2986. PubMed ID: 36841866 [TBL] [Abstract][Full Text] [Related]
33. Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence Tomography. Hariri AH; Zhang HY; Ho A; Francis P; Weleber RG; Birch DG; Ferris FL; Sadda SR; JAMA Ophthalmol; 2016 Jun; 134(6):628-35. PubMed ID: 27031504 [TBL] [Abstract][Full Text] [Related]
34. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2. Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297 [TBL] [Abstract][Full Text] [Related]
35. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease. Cai CX; Light JG; Handa JT Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757 [TBL] [Abstract][Full Text] [Related]
36. Morphological and functional changes in spectral domain optical coherence tomography and microperimetry in macular microhole variants: spectral domain optical coherence tomography and microperimetry correlation. Gella L; Raman R; Pal SS; Nittala MG; Sharma T Indian J Ophthalmol; 2012; 60(1):53-6. PubMed ID: 22218248 [TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study-Report No. 1. Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K Sci Rep; 2020 Oct; 10(1):16594. PubMed ID: 33024250 [TBL] [Abstract][Full Text] [Related]
38. Correlation of structure and function of the macula in patients with retinitis pigmentosa. Battu R; Khanna A; Hegde B; Berendschot TT; Grover S; Schouten JS Eye (Lond); 2015 Jul; 29(7):895-901. PubMed ID: 25952950 [TBL] [Abstract][Full Text] [Related]
39. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. Chew EY; Clemons TE; Jaffe GJ; Johnson CA; Farsiu S; Lad EM; Guymer R; Rosenfeld P; Hubschman JP; Constable I; Wiley H; Singerman LJ; Gillies M; Comer G; Blodi B; Eliott D; Yan J; Bird A; Friedlander M; Ophthalmology; 2019 Apr; 126(4):540-549. PubMed ID: 30292541 [TBL] [Abstract][Full Text] [Related]
40. Early deterioration in ellipsoid zone in eyes with non-neovascular age-related macular degeneration. Toprak I; Yaylalı V; Yildirim C Int Ophthalmol; 2017 Aug; 37(4):801-806. PubMed ID: 27591785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]